CD22 Antibody [hL22 (Epratuzumab) ], Human IgG1 | 24-491

CD22 Antibody [hL22 (Epratuzumab) ], Human IgG1 | 24-491 | Gentaur UK, US & Europe Distribution

Product Type: Primary Antibodies, Drug Analogues

Research Area: Cancer, Immunology, Other

Host Species: N/A

Species Reactivity: Human, Rhesus Monkey, Cynomolgus Monkey

Homology: N/A

Immunogen: This antibody was prepared by the humanization of LL2 (EPB-2), a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5–10% of the molecule, with the remainder being human framework sequences, which greatly reduces the potential for immunogenicity (Traczewski, 2010) .

Tested Application: Bl, IP, Flow

Predicted MW: N/A

Purification: N/A

Clonality: N/A

Clone: hL22 (Epratuzumab)

Isotype: IgG1 kappa

Conjugate: Unconjugated

Physical State: N/A

Buffer: PBS with 0.02% Proclin 300.

Concentration: batch dependent

Storage: Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at -20⁰C.

Additional Names: Leu14, B-cell receptor CD22, B-lymphocyte cell adhesion molecule, BL-CAM, Sialic acid-binding Ig-like lectin 2, Siglec-2, T-cell surface antigen Leu-14

Background: N/A

Shipping Condition: Blue Ice

Source: N/A

Species: Human

Peptide Location: N/A

By Source: N/A

By Species: N/A

Recombinant Protein Sequence: N/A

Badges: N/A